Bär & Karrer
  • en
  • de
  • fr
  • Lawyers
  • Expertise
  • Deals, Cases & News
  • Publications
  • Career
contact
search
  • Lawyers
  • Expertise
  • Deals, Cases & News
  • Publications
  • Career
  • About us
  • Diversity & Inclusion
  • Alumni
  • Newsletter
  • Contact
  • Imprint
  • Terms of Use
  • Privacy Policy
  • en
  • de
  • fr
LinkedIn
Diversity & Inclusion - 19 October 2021

A diverse and inclusive working environment

Read More
default
08 February 2017 I Briefing

New Regulations Regarding Drug Pricing

Bär & Karrer Briefing February 2017

Download
TagHealthcare & Life Sciences
Authors
Partner

Prof. Dr. Markus
Schott

Partner

Dr. Markus
Wang

Further Briefings

Briefing - 31 May 2022

Brexit and the Recognition and Enforcement of UK Judgments in Switzerland – ...

Nadja Jaisli Kull Aurélie Conrad HariDr. Romana Brueggemann Nadine Pfiffner

Bär & Karrer Briefing May 2022

Read More
Briefing - 23 March 2022

Ukraine War: Protection Status S

Thomas StoltzSilke Skowronek Özden Omürcan

Bär & Karrer Briefing March 2022

Read More
Briefing - 09 February 2022

China’s New Privacy Law - What Swiss Companies Should Know

Dr. Jan KleinerDr. Rehana Harasgama Viviane Berger

Bär & Karrer Briefing February 2022

Read More
Briefing - 03 January 2022

New ESG Due Diligence and Reporting Obligations

Dr. Vera Naegeli

Bär & Karrer Briefing January 2022

Read More
Briefing - 17 November 2021

Green Light for Swiss SPACs: New Rules for the Listing of SPACs on SIX ...

Dr. Urs Kägi Lukas Roesler Stefanie WalchDr. Linus Zweifel

Bär & Karrer Briefing November 2021

Read More
Briefing - 13 September 2021

Switzerland Recognises the EU Standard Contractual Clauses. Are Swiss Data ...

Dr. Corrado RampiniDr. Christian KunzDr. Rehana Harasgama

Bär & Karrer Briefing September 2021

Read More
All Briefings
  • Lawyers
  • Expertise
  • Deals, Cases & News
  • Publications
  • Career
  • About us
  • Diversity & Inclusion
  • Alumni
  • Contact
  • Imprint
  • Terms of Use
  • Privacy Policy